New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population

Dementia and Geriatric Cognitive Disorders

Volumn 30, Issue 1, 2010, Pages 1-7

  Bouwman, F H ^a   Verwey, N A ^a,b   Klein, M ^b   Kok, A ^b   Blankenstein, M A ^b   Sluimer, J D ^b   Barkhof, F ^b   Van Der Flier, W M ^a,b   Scheltens, P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer; Cerebrospinal fluid; Cognitive impairment; MRI

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; TAU PROTEIN; THREONINE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CEREBROSPINAL FLUID; CLINICAL ASSESSMENT; CONTROLLED STUDY; EPISODIC MEMORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MEMORY; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

AGED; ALZHEIMER DISEASE; AMBULATORY CARE FACILITIES; AMYLOID BETA-PEPTIDES; COGNITION DISORDERS; DATA INTERPRETATION, STATISTICAL; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIKELIHOOD FUNCTIONS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; TAU PROTEINS;

EID: 77954181615     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000315542     Document Type: Article

References (24)

1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
2. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, Small GW, Miller B, Stevens JC: Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1143-1153.
3. Morris JC, Price AL: Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci 2001; 17: 101-118.
4. Korf ES, Wahlund LO, Visser PJ, Scheltens P: Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology 2004; 63: 94-100.
5. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J: Atrophy of medial temporal lobes on MRI in 'probable' Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992; 55: 967-972.
6. Blennow K, Hampel H: CSF markers for incipient Alzheimer's disease. Lancet Neurol 2003; 2: 605-613.
7. Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P: Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734-746.
8. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-1554.
9. Roman GC, Tatemichi TK, Erkinjuntti T, et al: Vascular dementia: diagnostic criteria for research studies: report of the NINDSAIREN International Workshop. Neurology 1993; 43: 250-260.
10. McKeith IG: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis 2006; 9: 417-423.
11. Gibb WR, Luthert PJ, Marsden CD: Corticobasal degeneration. Brain 1989; 112: 1171-1192.
12. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS: Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson- Olszewski syndrome): report of the NINDSSPSP international workshop. Neurology 1996; 47: 1-9.
13. Rebeiz JJ, Kolodny EH, Richardson EP Jr: Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968; 18: 20-33.
14. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-308.
15. Petersen RC, Morris JC: Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 2005; 62: 1160-1163.
16. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
17. Lindeboom J, Schmand B, Tulner L, Walstra G, Jonker C: Visual association test to detect early dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry 2002; 73: 126-133.
18. Consensus report of the Working Group on: 'Molecular and Biochemical Markers of Alzheimer's Disease'. The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group. Neurobiol Aging 1998; 19: 109-116.
19. Schoonenboom N, Visser P, Mulder C, Lindeboom J, Van Elk EJ, Van Kamp GJ, Scheltens P: Biomarker profiles and their relation to clinical variables in mild cognitive impairment. Neurocase 2005; 11: 8-13.
20. Schoonenboom NS, Pijnenburg YA, Mulder C, Rosso SM, Van Elk EJ, Van Kamp GJ, Van Swieten JC, Scheltens P: Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease. Neurology 2004; 62: 1580-1584.
21. Frisoni GB, Laakso MP, Beltramello A, Geroldi C, Bianchetti A, Soininen H, Trabucchi M: Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease. Neurology 1999; 52: 91-100.
22. Laakso MP, Partanen K, Riekkinen P, Lehtovirta M, Helkala EL, Hallikainen M, Hanninen T, Vainio P, Soininen H: Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: an MRI study. Neurology 1996; 46: 678-681.
23. van de Pol LA, Hensel A, Barkhof F, Gertz HJ, Scheltens P, Van der Flier WM: Hippocampal atrophy in Alzheimer disease: age matters. Neurology 2006; 66: 236-238.
24. Coleman RE: Positron emission tomography diagnosis of Alzheimer's disease. Neuroimaging Clin N Am 2005; 15: 837-846.